Novel molecular targets for the treatment of obesity

[1]  M. Bayne,et al.  Cloning and Expressional Characterization of a Novel Galanin Receptor , 1997, The Journal of Biological Chemistry.

[2]  R. L. Dow.  β3-adrenergic agonists: potential therapeutics for obesity , 1997 .

[3]  R. Cone,et al.  Independent and additive effects of central POMC and leptin pathways on murine obesity. , 1997, Science.

[4]  R. Seeley,et al.  Melanocortin receptors in leptin effects , 1997, Nature.

[5]  P. Hipskind,et al.  Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists. , 1997, Journal of medicinal chemistry.

[6]  S. Whitebread,et al.  Inhibition of Food Intake by Neuropeptide Y Y5 Receptor Antisense Oligodeoxynucleotides , 1997, Diabetes.

[7]  D. Romsos,et al.  Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice. , 1997, The Journal of nutrition.

[8]  R. Unger,et al.  Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. , 1997, The Journal of clinical investigation.

[9]  A. Sleight,et al.  Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder. , 1997, Journal of medicinal chemistry.

[10]  A. Blomqvist,et al.  Y-receptor subtypes—how many more? , 1997, Trends in Neurosciences.

[11]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[12]  C. Newgard,et al.  Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Lowell,et al.  UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. , 1997, Biochemical and biophysical research communications.

[14]  J. Wong,et al.  Obesity, Diabetes and Functions for Proopiomelanocortin-derived Peptides , 1997, Molecular and Cellular Endocrinology.

[15]  L. V. D. van der Ploeg,et al.  Molecular cloning and characterization of a new receptor for galanin , 1997, FEBS letters.

[16]  Christophe Fleury,et al.  Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia , 1997, Nature Genetics.

[17]  G. Barsh,et al.  Effects of recombinant agouti-signaling protein on melanocortin action. , 1997, Molecular endocrinology.

[18]  C. Strader,et al.  Diet-induced obese mice develop peripheral, but not central, resistance to leptin. , 1997, The Journal of clinical investigation.

[19]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[20]  W. Banks,et al.  Leptin enters the brain by a saturable system independent of insulin , 1996, Peptides.

[21]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[22]  T. Tanaka,et al.  Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. , 1996, Endocrinology.

[23]  R. Considine,et al.  Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance , 1996, The Lancet.

[24]  S. Whitebread,et al.  A receptor subtype involved in neuropeptide-Y-induced food intake , 1996, Nature.

[25]  D. Porte,et al.  Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans , 1996, Nature Medicine.

[26]  M. Phillips,et al.  Leptin receptor missense mutation in the fatty Zucker rat , 1996, Nature Genetics.

[27]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[28]  B. Lowell,et al.  Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action , 1995, Nature Medicine.

[29]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[30]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[31]  J. Leban,et al.  High-affinity neuropeptide Y receptor antagonists. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Lönnqvist,et al.  Overexpression of the obese (ob) gene in adipose tissue of human obese subjects , 1995, Nature Medicine.

[33]  M. Deitel,et al.  Increased obese mRNA expression in omental fat cells from massively obese humans , 1995, Nature Medicine.

[34]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[35]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[36]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[37]  R. Considine,et al.  Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. , 1995, The Journal of clinical investigation.

[38]  R. Quirion,et al.  Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors. , 1995, European journal of pharmacology.

[39]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[40]  F. Oury-Donat,et al.  SR120819A, an orally‐active and selective neuropeptide Y Y1 receptor antagonist , 1995, FEBS letters.

[41]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[42]  Y Watanabe,et al.  Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Mayaux,et al.  Molecular cloning of a functional human galanin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. G. Dube,et al.  Evidence that neuropeptide Y is a physiological signal for normal food intake , 1994, Brain Research.

[45]  D. Smith,et al.  Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Leibowitz,et al.  Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion , 1992, Brain Research.

[47]  S. Liggett.  Functional properties of the rat and human beta 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells. , 1992, Molecular pharmacology.

[48]  S. Leibowitz,et al.  Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect , 1992, Peptides.

[49]  J. Cidlowski,et al.  Internucleosomal deoxyribonucleic acid cleavage activity in apoptotic thymocytes: detection and endocrine regulation. , 1991, Endocrinology.

[50]  G. Fisone,et al.  Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[51]  R. Jung,et al.  Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical β adrenoceptor agonist , 1988, British medical journal.

[52]  S. Kalra,et al.  Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus , 1988, Peptides.

[53]  M. Sennitt,et al.  Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs , 1984, Nature.

[54]  Jon L. Wright.  Design and discovery of neuropeptide Y1 receptor antagonists , 1997 .

[55]  D. Smith,et al.  Neuropeptide Y Induced Feeding in the Rat Is Mediated by a Novel Receptor1. , 1997, Endocrinology.

[56]  C. Wahlestedt,et al.  Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. , 1994, Brain research. Molecular brain research.